Comparative in vitro activity of doxycycline and oxytetracycline against porcine respiratory pathogens

被引:26
|
作者
Bousquet, E
Morvan, H
Aitken, I
Morgan, JH
机构
[1] LAB DEV & ANAL,F-22440 PLOUFRAGAN,FRANCE
[2] INST ANIM HLTH,NEWBURY RG20 7NN,BERKS,ENGLAND
关键词
D O I
10.1136/vr.141.2.37
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Minimum inhibitory concentrations of doxycycline and oxytetracycline were determined against 55 Pasteurella multocida strains, 59 Actinobacillus pleuropneumoniae strains and 26 Mycoplasma hyopneumoniae strains isolated from the respiratory tract of pigs, An additional set of 76 P multocida strains isolated from pneumonic pigs was tested for their minimum inhibitory concentrations of doxycycline, The P multocida and A pleuropneumoniae strains were isolated in France and the minimum inhibitory concentrations were determined by an agar dilution method, The M hyopneumoniae strains were isolated in the United Kingdom and minimum inhibitory concentrations were determined by a serial broth dilution method, All the strains tested were susceptible to doxycycline whereas 15 per cent of the P multocida strains and 22 per cent of the A pleuropneumoniae strains were resistant to oxytetracycline. Doxycycline concentrations inhibiting 90 per cent of strains were 1 mu g/ml for P multocida and 2 mu g/ml for A pleuropneumoniae. The ratio of the minimum inhibitory concentrations of doxycycline and oxytetracycline ranged between 1/1 and 1/4 for the oxytetracycline-susceptible strains and between 1/16 and 1/64 for the oxytetracycline-resistant strains. All the M hyopneumoniae strains were susceptible to doxycycline and oxytetracycline, the concentrations inhibiting 90 per cent of strains being 1 mu g/ml and 2 mu g/ml, respectively. These data confirm that doxycycline has a higher in vitro activity against pig respiratory pathogens than oxytetracycline.
引用
收藏
页码:37 / 40
页数:6
相关论文
共 50 条
  • [21] In Vitro and In Vivo Activity of Moxifloxacin against Community Respiratory Tract Pathogens
    J. M. Blondeau
    D. Felmingham
    Clinical Drug Investigation, 1999, 18 : 57 - 78
  • [22] In vitro antimicrobial activity of plant fractions against major respiratory pathogens
    Abbas, Tanveer
    Sara, Bisma
    Shoaib, Affhan
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 33 (06) : 2557 - 2565
  • [23] COMPARATIVE ANTIMICROBIAL ACTIVITY OF THE NEW MACROLIDE FLURITHROMYCIN AGAINST RESPIRATORY PATHOGENS
    NORD, CE
    LINDMARK, A
    PERSSON, I
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1988, 7 (01) : 71 - 73
  • [24] Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections
    Hicks, PS
    Pelak, B
    Woods, GL
    Bartizal, KF
    Motyl, M
    CLINICAL MICROBIOLOGY AND INFECTION, 2002, 8 (11) : 753 - 757
  • [25] Quinolone Activity Against Respiratory Pathogens
    B. Wiedemann
    Drugs, 1999, 58 : 415 - 416
  • [26] Quinolone activity against respiratory pathogens
    Wiedemann, B
    DRUGS, 1999, 58 (Suppl 2) : 415 - 416
  • [27] Activity of cefditoren against respiratory pathogens
    Clark, CL
    Nagai, K
    Dewasse, BE
    Pankuch, GA
    Ednie, LM
    Jacobs, MR
    Appelbaum, PC
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (01) : 33 - 41
  • [28] ACTIVITY OF TEMAFLOXACIN AGAINST RESPIRATORY PATHOGENS
    SWANSON, RN
    HARDY, DJ
    CHU, DTW
    SHIPKOWITZ, NL
    CLEMENT, JJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (03) : 423 - 429
  • [29] In vitro antibacterial activity of gemifloxacin and comparator compounds against common respiratory pathogens
    Rittenhouse, S
    McCloskey, L
    Broskey, J
    Niconovich, N
    Jakielaszek, C
    Poupard, J
    Coleman, K
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 : 23 - 27
  • [30] In vitro activity of minocycline against respiratory pathogens from patients with cystic fibrosis
    Kurlandsky, LE
    Fader, RC
    PEDIATRIC PULMONOLOGY, 2000, 29 (03) : 210 - 212